Literature DB >> 25346641

What you seize is what you get: do we yet understand epilepsy in rett syndrome?

Tim A Benke.   

Abstract

Entities:  

Year:  2014        PMID： 25346641      PMCID： PMC4189644          DOI： 10.5698/1535-7597-14.5.283

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN： 1535-7511            Impact factor:   7.500


× No keyword cloud information.
  22 in total

1.  Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice.

Authors:  R Z Chen; S Akbarian; M Tudor; R Jaenisch
Journal:  Nat Genet       Date:  2001-03       Impact factor: 38.330

2.  Genotype-phenotype relationships as prognosticators in Rett syndrome should be handled with care in clinical practice.

Authors:  Nicky S J Halbach; Eric E J Smeets; Noortje van den Braak; Kees E P van Roozendaal; Rien M J Blok; Constance T R M Schrander-Stumpel; Jean-Pierre Frijns; Marian A Maaskant; Leopold M G Curfs
Journal:  Am J Med Genet A       Date:  2011-12-21       Impact factor: 2.802

3.  Absence seizures in succinic semialdehyde dehydrogenase deficient mice: a model of juvenile absence epilepsy.

Authors:  M A Cortez; Y Wu; K M Gibson; O C Snead
Journal:  Pharmacol Biochem Behav       Date:  2004-11       Impact factor: 3.533

4.  Temperature- and age-dependent seizures in a mouse model of severe myoclonic epilepsy in infancy.

Authors:  John C Oakley; Franck Kalume; Frank H Yu; Todd Scheuer; William A Catterall
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-20       Impact factor: 11.205

5.  Systemic delivery of MeCP2 rescues behavioral and cellular deficits in female mouse models of Rett syndrome.

Authors:  Saurabh K Garg; Daniel T Lioy; Hélène Cheval; James C McGann; John M Bissonnette; Matthew J Murtha; Kevin D Foust; Brian K Kaspar; Adrian Bird; Gail Mandel
Journal:  J Neurosci       Date:  2013-08-21       Impact factor: 6.167

6.  Specific mutations in methyl-CpG-binding protein 2 confer different severity in Rett syndrome.

Authors:  J L Neul; P Fang; J Barrish; J Lane; E B Caeg; E O Smith; H Zoghbi; A Percy; D G Glaze
Journal:  Neurology       Date:  2008-03-12       Impact factor: 9.910

Review 7.  Neurophysiology of Rett syndrome.

Authors:  Daniel G Glaze
Journal:  Ment Retard Dev Disabil Res Rev       Date:  2002

8.  Ethosuximide reduces epileptogenesis and behavioral comorbidity in the GAERS model of genetic generalized epilepsy.

Authors:  Gabi Dezsi; Ezgi Ozturk; Davor Stanic; Kim L Powell; Hal Blumenfeld; Terence J O'Brien; Nigel C Jones
Journal:  Epilepsia       Date:  2013-03-06       Impact factor: 5.864

9.  Rett syndrome: revised diagnostic criteria and nomenclature.

Authors:  Jeffrey L Neul; Walter E Kaufmann; Daniel G Glaze; John Christodoulou; Angus J Clarke; Nadia Bahi-Buisson; Helen Leonard; Mark E S Bailey; N Carolyn Schanen; Michele Zappella; Alessandra Renieri; Peter Huppke; Alan K Percy
Journal:  Ann Neurol       Date:  2010-12       Impact factor: 10.422

10.  Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes.

Authors:  Hsiao-Tuan Chao; Hongmei Chen; Rodney C Samaco; Mingshan Xue; Maria Chahrour; Jong Yoo; Jeffrey L Neul; Shiaoching Gong; Hui-Chen Lu; Nathaniel Heintz; Marc Ekker; John L R Rubenstein; Jeffrey L Noebels; Christian Rosenmund; Huda Y Zoghbi
Journal:  Nature       Date:  2010-11-11       Impact factor: 49.962
View more
  2 in total

1.  Longitudinal course of epilepsy in Rett syndrome and related disorders.

Authors:  Daniel C Tarquinio; Wei Hou; Anne Berg; Walter E Kaufmann; Jane B Lane; Steven A Skinner; Kathleen J Motil; Jeffrey L Neul; Alan K Percy; Daniel G Glaze
Journal:  Brain       Date:  2016-12-21       Impact factor: 13.501

2.  Heightened Delta Power during Slow-Wave-Sleep in Patients with Rett Syndrome Associated with Poor Sleep Efficiency.

Authors:  Simon Ammanuel; Wesley C Chan; Daniel A Adler; Balaji M Lakshamanan; Siddharth S Gupta; Joshua B Ewen; Michael V Johnston; Carole L Marcus; Sakkubai Naidu; Shilpa D Kadam
Journal:  PLoS One       Date:  2015-10-07       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.